The requirement of elevated MMP secretion in diseases such as HHT is evidenced by the fact patients with AVMs show elevated MMP9 and MMP2 expression in plasma and tissue samples (Liu et al., 2035; Wei et al., 2016). The gene discussed is MMP2; the disease is hereditary hemorrhagic telangiectasia.